Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
Statins are currently the treatment of choice for hypercholesterolemia. However, wide interindividual variability has been observed in the response to treatment. Recent studies have reported the role of lncRNAs in the metabolism of lipids; nevertheless, there are few studies to date that show their...
Main Authors: | Isis Paez, Yalena Prado, Pía Loren, Carmen G. Ubilla, Nelia Rodríguez, Luis A. Salazar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/742 |
Similar Items
-
Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
by: Isis Paez, et al.
Published: (2020-11-01) -
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
by: Carmen Gloria Ubilla, et al.
Published: (2021-05-01) -
MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
by: Kathleen Saavedra, et al.
Published: (2022-04-01) -
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
by: Yutong Zhang, et al.
Published: (2023-09-01) -
Comparative effects of garlic (Allium sativum) powder and atorvastatin in female reproductive system of hypercholesterolemic rats: A histological and biochemical evaluation
by: Sima Jafari, et al.
Published: (2021-09-01)